Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia

PURPOSE: Colistin alone may not be sufficient for treating carbapenem-resistant Acinetobacter baumannii (CRAB); thus, efforts are needed to increase treatment success rates. We compared the effects of colistin plus carbapenem therapy versus colistin monotherapy in treating pneumonia caused by CRAB a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, HyeJin, Lee, Jin Seo, Park, So Yeon, Ko, Yousang, Eom, Joong Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934122/
https://www.ncbi.nlm.nih.gov/pubmed/31920347
http://dx.doi.org/10.2147/IDR.S234211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934122/
https://www.ncbi.nlm.nih.gov/pubmed/31920347
http://dx.doi.org/10.2147/IDR.S234211

Ejemplares similares